FBIOP

#11582
Fortress Biotech, Inc.
13.38 USD
-2.19%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
13.31
13.46
Year Range
4.72
14.64
Daily Change
-2.19%
Monthly Change
+3.32%
6 month change
+89.25%
Year Change
+164.95%
Previous Close
13.68
Open
13.31
Bid
Ask
Low
13.31
High
13.46
Volume
6
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 85.51 M
  • Employee 101
  • Founded 2006
  • CEO Lindsay Rosenwald
  • Website www.fortressbiotech.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2MFH6
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-135.57
Price to sales ratio
4.19

Fortress Biotech Inc - 9.375% Series A Cumulative Redeemable Pe

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

News